SCHEMBL19677574

SCHEMBL19677574

C#CCOc1c(I)cc(Oc2c(I)cc(CC(=O)OC)cc2I)cc1I

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 10/20 0.51
▸ THRA P10827 8/20 0.51
▸ PPARG P37231 6/20 0.51
▸ RXRA P19793 3/20 0.51
▸ ITGB3 P05106 1/20 0.51
▸ ITGAV P06756 1/20 0.51
▸ PCNA P12004 11/20 0.44
▸ LMNA P02545 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ ADORA3 P0DMS8 3/20 0.43
▸ PDE4D Q08499 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ TTR P02766 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ HTR1A P08908 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ HTR2B P41595 2/20 0.43
▸ PGR P06401 2/20 0.43
▸ NR3C1 P04150 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19665912 0.86 THRB (0.66) THRBTHRAPPARGRXRAITGB3
SCHEMBL1525946 0.83 THRB (0.73) THRBTHRAPPARGRXRAITGB3
SCHEMBL23984198 0.81 HSP90AB1 (0.41) THRBTHRAPPARGRXRAITGB3
SCHEMBL6857392 0.81 THRB (0.52) THRBTHRAPPARGRXRAITGB3
SCHEMBL6852102 0.80 THRB (0.51) THRBTHRAPPARGRXRAITGB3
SCHEMBL6852396 0.76 THRB (0.47) THRBTHRAPPARGRXRAITGB3
SCHEMBL5742498 0.76 PCNA (0.53) THRBTHRAPPARGRXRAITGB3
SCHEMBL19665929 0.76 THRB (0.37) THRBTHRAPPARGRXRAITGB3
SCHEMBL5741869 0.75 PCNA (0.62) THRBTHRAPPARGRXRAITGB3
SCHEMBL19679558 0.73 THRB (0.62) THRBTHRAPPARGRXRAITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10695436-B2 Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists NANOPHARMACEUTICALS, LLC (US) 2020-06-30 — — US disclosed
US-20190111145-A1 NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS NANOPHARMACEUTICALS, LLC 2019-04-18 — — US disclosed
US-10201616-B2 Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists NANOPHARMACEUTICALS, LLC (US) 2019-02-12 — — US disclosed
US-20170348425-A1 NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS NANOPHARMACEUTICALS, LLC 2017-12-07 — — US disclosed
US-20170348425-A1 NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS NANOPHARMACEUTICALS, LLC 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10201616-B2 Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists CD44, THRA, TSHR THRB 6/4885THRA 2/4885PPARG 955/4885
US-20170348425-A1 NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS THRA, CD44, ITGAV THRB 5/4885THRA 1/4885PPARG 861/4885
US-20190111145-A1 NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS THRA, CD44, ITGAV THRB 5/4885THRA 1/4885PPARG 861/4885
US-10695436-B2 Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists THRA, CD44, ITGAV THRB 5/4885THRA 1/4885PPARG 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback